Many Medicaid Enrollees with Opioid Use Disorder Were Treated with Medication; However, Disparities Present Concerns

What's New

October 2, 2023

Biosimilars Have Lowered Costs for Medicare Part B and Enrollees, but Opportunities for Substantial Spending Reductions Still Exist OEI-05-22-00140

September 29, 2023

Many Medicaid Enrollees with Opioid Use Disorder Were Treated with Medication; However, Disparities Present Concerns OEI-BL-22-00260

District of Columbia Medicaid Fraud Control Unit: 2022 Onsite Review OEI-06-22-00420

September 28, 2023

Advisory Opinion 23-06 Unfavorable opinion regarding a laboratory company’s proposal to purchase anatomic pathology services from third-party laboratories.

Enforcement Actions

September 29, 2023; U.S. Department of Justice

South Carolina Physician and Nephrology Practice Agree to Pay Over $585,000 to Settle Laboratory Kickback Allegations

September 29, 2023; U.S. Attorney's Office, Eastern District of Virginia

Behavioral Services Healthcare Provider and its Owner Settle False Claims Act Allegations

September 30, 2023; U.S. Department of Justice

Cigna Group to Pay $172 Million to Resolve False Claims Act Allegations

September 30, 2023; U.S. Attorney's Office, Eastern District of Pennsylvania

Cigna Group to Pay $172 Million to Resolve False Claims Act Allegations

What's Trending

1. Medicare Advantage Compliance Audit of Diagnosis Codes That Health Net of California, Inc. (Contract H0562) Submitted to CMS
2. Managed Care Featured Topic
3. Employee Profile: Patrick Neubert
4. Fraud Alert: Scammers Steal Money From the Public Through Fake HHS Websites and Social Media Schemes
5. Alabama Did Not Always Invoice Rebates to Manufacturers for Pharmacy and Physician-Administered Drugs